CC-38 clinical trials

A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

This early-stage study is testing a new type of immunotherapy called CC-38 for people with advanced bowel cancer or prostate cancer. It uses your own immune cells to try and fight the cancer. We want to see if this treatment is safe and effective.